As a board member of the Alliance of Wound Care Stakeholders, I invite you to our upcoming Wound Care Evidence Summit where we will explore the key question: What type and quantity of clinical evidence is required by payers in formulating positive coverage policies for wound care products and procedures?
If you are involved in the field of wound care, you know that wound care coverage policies are becoming increasingly restrictive. You try to get the payer to approve the use of a product that’s available on the market and that works in your hands, only to be told it isn’t covered because the payer isn’t convinced by the data. Or, you are pretty sure that a product will help a patient with a limb-threatening wound … read more
Help support non-profit medical journalism. If you find WoundCareWeekly.com of value please consider a monthly donation to help cover expenses and keep this website going.